|
1
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hardie DG and Carling D: The AMP-activated
protein kinase - fuel gauge of the mammalian cell? Eur J Biochem.
246:259–273. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Imamura K, Ogura T, Kishimoto A, Kaminishi
M and Esumi H: Cell cycle regulation via p53 phosphorylation by a
5′-AMP activated protein kinase activator,
5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, in a human
hepatocellular carcinoma cell line. Biochem Biophys Res Commun.
287:562–567. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inoki K, Zhu T and Guan KL: TSC2 mediates
cellular energy response to control cell growth and survival. Cell.
115:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maxwell PH, Dachs GU, Gleadle JM, Nicholls
LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW and Ratcliffe PJ:
Hypoxia-inducible factor-1 modulates gene expression in solid
tumors and influences both angiogenesis and tumor growth. Proc Natl
Acad Sci USA. 94:8104–8109. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salceda S and Caro J: Hypoxia-inducible
factor 1alpha (HIF-1alpha) protein is rapidly degraded by the
ubiquitin-proteasome system under normoxic conditions. Its
stabilization by hypoxia depends on redox-induced changes. J Biol
Chem. 272:22642–22647. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin R, Maeda S, Liu C, Karin M and
Edgington TS: A large noncoding RNA is a marker for murine
hepatocellular carcinomas and a spectrum of human carcinomas.
Oncogene. 26:851–858. 2007. View Article : Google Scholar
|
|
10
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar
|
|
11
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar
|
|
12
|
Xu C, Yang M, Tian J, Wang X and Li Z:
MALAT-1: A long non-coding RNA and its important 3′ end functional
motif in colorectal cancer metastasis. Int J Oncol. 39:169–175.
2011.PubMed/NCBI
|
|
13
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, et al:
Long noncoding RNA MALAT1 controls cell cycle progression by
regulating the expression of oncogenic transcription factor B-MYB.
PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eissmann M, Gutschner T, Hämmerle M,
Günther S, Caudron-Herger M, Gross M, Schirmacher P, Rippe K, Braun
T, Zörnig M, et al: Loss of the abundant nuclear non-coding RNA
MALAT1 is compatible with life and development. RNA Biol.
9:1076–1087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lelli A, Nolan KA, Santambrogio S,
Gonçalves AF, Schönenberger MJ, Guinot A, Frew IJ, Marti HH,
Hoogewijs D and Wenger RH: Induction of long non coding RNA MALAT1
in hypoxic mice. Hypoxia (Auckl). 2015:45–52. 2015.
|
|
20
|
Miard S, Dombrowski L, Carter S, Boivin L
and Picard F: Aging alters PPARgamma in rodent and human adipose
tissue by modulating the balance in steroid receptor coactivator-1.
Aging Cell. 8:449–459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al: Role of
AMP-activated protein kinase in mechanism of metformin action. J
Clin Invest. 108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Evans JM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu D, Wakabayashi Y, Lippincott-Schwartz J
and Arias IM: Bile acid stimulates hepatocyte polarization through
a cAMP-Epac-MEK-LKB1-AMPK pathway. Proc Natl Acad Sci USA.
108:1403–1408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lo B, Strasser G, Sagolla M, Austin CD,
Junttila M and Mellman I: Lkb1 regulates organogenesis and early
oncogenesis along AMPK-dependent and -independent pathways. J Cell
Biol. 199:1117–1130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Enserink JM, Christensen AE, de Rooij J,
van Triest M, Schwede F, Genieser HG, Døskeland SO, Blank JL and
Bos JL: A novel Epac-specific cAMP analogue demonstrates
independent regulation of Rap1 and ERK. Nat Cell Biol. 4:901–906.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda
M, Saji I and Kobayashi R: STO-609, a specific inhibitor of the
Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem.
277:15813–15818. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC,
Kim MS and Park JW: YC-1: A potential anticancer drug targeting
hypoxia-inducible factor 1. J Natl Cancer Inst. 95:516–525. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Laderoute KR, Amin K, Calaoagan JM, Knapp
M, Le T, Orduna J, Foretz M and Viollet B: 5′-AMP-activated protein
kinase (AMPK) is induced by low-oxygen and glucose deprivation
conditions found in solid-tumor microenvironments. Mol Cell Biol.
26:5336–5347. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shaw RJ, Kosmatka M, Bardeesy N, Hurley
RL, Witters LA, DePinho RA and Cantley LC: The tumor suppressor
LKB1 kinase directly activates AMP-activated kinase and regulates
apoptosis in response to energy stress. Proc Natl Acad Sci USA.
101:3329–3335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mungai PT, Waypa GB, Jairaman A, Prakriya
M, Dokic D, Ball MK and Schumacker PT: Hypoxia triggers AMPK
activation through reactive oxygen species-mediated activation of
calcium release-activated calcium channels. Mol Cell Biol.
31:3531–3545. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arnould T, Michiels C, Alexandre I and
Remacle J: Effect of hypoxia upon intracellular calcium
concentration of human endothelial cells. J Cell Physiol.
152:215–221. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Y, Guo B, Xie Q, Ye D, Zhang D, Zhu Y,
Chen H and Zhu B: STIM1 mediates hypoxia-driven
hepatocarcinogenesis via interaction with HIF-1. Cell Rep.
12:388–395. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mottet D, Michel G, Renard P, Ninane N,
Raes M and Michiels C: ERK and calcium in activation of HIF-1. Ann
NY Acad Sci. 973:448–453. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mottet D, Michel G, Renard P, Ninane N,
Raes M and Michiels C: Role of ERK and calcium in the
hypoxia-induced activation of HIF-1. J Cell Physiol. 194:30–44.
2003. View Article : Google Scholar
|
|
35
|
Berchner-Pfannschmidt U, Petrat F, Doege
K, Trinidad B, Freitag P, Metzen E, de Groot H and Fandrey J:
Chelation of cellular calcium modulates hypoxia-inducible gene
expression through activation of hypoxia-inducible factor-1alpha. J
Biol Chem. 279:44976–44986. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hui AS, Bauer AL, Striet JB, Schnell PO
and Czyzyk-Krzeska MF: Calcium signaling stimulates translation of
HIF-alpha during hypoxia. FASEB J. 20:466–475. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma XY, Wang JH, Wang JL, Ma CX, Wang XC
and Liu FS: Malat1 as an evolutionarily conserved lncRNA, plays a
positive role in regulating proliferation and maintaining
undifferentiated status of early-stage hematopoietic cells. BMC
Genomics. 16:6762015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koumenis C, Alarcon R, Hammond E, Sutphin
P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, et al:
Regulation of p53 by hypoxia: Dissociation of transcriptional
repression and apoptosis from p53-dependent transactivation. Mol
Cell Biol. 21:1297–1310. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou CH, Zhang XP, Liu F and Wang W:
Modeling the interplay between the HIF-1 and p53 pathways in
hypoxia. Sci Rep. 5:138342015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sermeus A and Michiels C: Reciprocal
influence of the p53 and the hypoxic pathways. Cell Death Dis.
2:e1642011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schmid T, Zhou J, Köhl R and Brüne B: p300
relieves p53-evoked transcriptional repression of hypoxia-inducible
factor-1 (HIF-1). Biochem J. 380:289–295. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tee AE, Liu B, Song R, Li J, Pasquier E,
Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, et al: The
long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by
up-regulating pro-angiogenic gene expression. Oncotarget.
7:8663–8675. 2016.PubMed/NCBI
|
